Article

Clinico-radiological outcomes in WNT-subgroup medulloblastoma

2024-01-16

Abstract excerpt

<h4>Background: </h4> Medulloblastoma (MB) comprises four broad molecular subgroups - wingless (WNT), sonic hedgehog (SHH), Group 3, and Group 4 respectively with subgroup-specific developmental origins, unique genetic profiles, distinct clinico-demographic characteristics, and diverse clinical outcomes. WNT-MB has the best outcomes (5-year survival >90%) with contemporary multi-modality treatment prompting att...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69400ce7-b7b9-56ba-9038-bf08fdcaa235
DOI: 10.20944/preprints202401.1198.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinico-radiological outcomes in WNT-subgroup medulloblastomaDOI 10.20944/preprints202401.1198.v1Read

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?Semantic proximity Read

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical PracticeSemantic proximity Read

Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomasSemantic proximity Read

Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsSemantic proximity Read

Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified ApproachSemantic proximity Read

Medulloblastoma in the Molecular EraSemantic proximity Read

Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.Semantic proximity Read

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).Semantic proximity Read

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma TreatmentSemantic proximity Read

Medulloblastoma in the age of molecular subgroups: a reviewSemantic proximity Read

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic InsightsSemantic proximity Read

Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroupsSemantic proximity Read